Time-resolved contrast-enhanced magnetic resonance angiography of the carotid arteries: diagnostic accuracy and inter-observer variability compared with selective catheter angiography

RATIONALE AND OBJECTIVES: To assess the diagnostic accuracy and interobserver variability of contrast-enhanced magnetic resonance angiography (CE-MRA) in a time-resolved technique compared with digital subtraction angiography (x-ray DSA) in patients with suspected stenoses of the internal carotid artery. MATERIALS AND METHODS: A total of 43 patients were enrolled in this prospective study. All patients underwent selective x-ray DSA involving a total of 84 carotid arteries. CE-MRA was performed in a time-resolved technique with a fast gradient-echo sequence on a 1.5 T MR scanner: TR 3.8 milliseconds, TE 1.49 milliseconds. Four consecutive measurements, each a duration of 10 seconds, were performed with omission of measuring bolus transit time. Four independent radiologists scored the degree of stenosis. The interobserver variability was calculated for CE-MRA and x-ray DSA. RESULTS: In the 43 cases, at least one MRA measurement showed arterial contrast without venous degradation. Compared with x-ray DSA the mean sensitivity and specificity for grading stenosis > or = 70% were 98% and 86%, respectively. The interobserver agreement was substantial with no significant difference between CE-MRA (kappa value 0.794) and x-ray DSA (kappa value 0.786). CONCLUSIONS: The short acquisition time of a fast CE-MRA sequence allows a selective visualization of the internal carotid arteries without degradation from venous enhancement. It is a reliable method with a good interobserver agreement.     

Infragenual cuff-compression reduces venous contamination in contrast-enhanced MR angiography of the calf

PURPOSE: To reduce venous contamination at the calf level in three-dimensional contrast-enhanced MR angiography (CE-MRA) by applying continuous infragenual cuff-compression. MATERIALS AND METHODS: Ten patients with clinically relevant peripheral arterial occlusive disease (PAOD) underwent dynamic three-dimensional CE-MRA of the calf. Six consecutive measurements were acquired with the first measurement serving as mask. Cuff-compression of 50 mmHg was attached below the knee. To allow intra-individual comparison, compression was applied unilaterally. The cuff was inflated three minutes before scanning and was continued throughout the MRA session. Venous contamination and arterial visualization scores were ranked using a five-point rating scale. Contrast-to-noise ratios (CNRs) of superficial enhancing calf-veins on the uncompressed and compressed calf sides were evaluated. An asymmetry index (AI) defined by CNR(mean) (uncompressed)/CNR(mean) (compressed) was introduced to describe the ratio in venous contrast agent supply between both sides quantitatively. RESULTS: Three-dimensional CE-MRA of the calves demonstrated significantly lower superficial venous contamination scores (P < 0.004) and clearly improved arterial visualization (P < 0.009) on the compressed side. Additionally, AI values were larger than 1 (P < 0.02), indicating a higher contrast agent supply in the superficial veins on the uncompressed side. CONCLUSION: Infragenual cuff-compression minimizes venous overlay in three-dimensional CE-MRA at calf level by reduction of contrast agent supply in the superficial veins.     

Low-dose, time-resolved, contrast-enhanced 3D MR angiography in cardiac and vascular diseases: correlation to high spatial resolution 3D contrast-enhanced MRA

AIM: To evaluate the effectiveness of low-dose, contrast-enhanced, time-resolved, three-dimensional (3D) magnetic resonance (MR) angiography (TR-MRA) in the assessment of various cardiac and vascular diseases, and to compare the results with high-resolution contrast-enhanced MRA (CE-MRA). MATERIALS AND METHODS: Thirty consecutive patients underwent contrast-enhanced 3D TR-MRA and high spatial resolution 3D CE-MRA for evaluation of cardiac and thoracic vascular diseases at 1.5 T, and neurovascular, abdominal and peripheral vascular diseases at 3T. Gadolinium-based contrast medium was administered at a constant dose of 5 ml for TR-MRA, and 20 ml (lower extremity 30 ml) for CE-MRA. Two readers evaluated image quality using a four-point scale (from 0=excellent to 3=non-diagnostic), artefacts and findings on both datasets. Interobserver variability was tested with kappa coefficient. RESULTS: The overall image quality for TR-MRA was in the diagnostic range (median 0, range 0-1; k=0.74). Readers demonstrated important additional dynamic information on TR-MRA in 28 of 30 patients (k=0.84). Confident evaluation of organ perfusion (n=23), arteriovenous malformation/fistula flow patterns (n=7), exclusion of intra-cardiac shunts (n=6), and assessment of stent and conduit patency (n=5) were performed by both readers using TR-MRA. Readers demonstrated fine vascular details with higher confidence in 10 patients on CE-MRA. Using CE-MRA, Reader 1 and 2 depicted anatomical details in 6 and 5 patients, respectively, only on CE-MRA. CONCLUSION: Low-dose TR-MRA yields rapid and important functional and anatomical information in patients with cardiac and vascular diseases. Due to limited spatial resolution, TR-MRA is inferior to CE-MRA in demonstrating fine vascular details.     

Focal liver masses: enhancement patterns on contrast-enhanced images--concordance of US scans with CT scans and MR images

PURPOSE: To assess prospectively the concordance of enhancement patterns of focal liver masses on contrast material-enhanced ultrasonographic (US) scans with patterns on contrast-enhanced computed tomographic (CT) scans or magnetic resonance (MR) images. MATERIALS AND METHODS: This study was approved by the institutional review board; patients gave informed consent. Contrast-enhanced US and contrast-enhanced CT or MR imaging were performed in 135 patients (62 men, 73 women; mean age, 51 years) with 144 confirmed liver masses. Masses included 49 hepatocellular carcinomas, 13 metastases, 30 hemangiomas, 41 lesions of focal nodular hyperplasia, and 11 others. Randomized image sets from each modality were shown independently to three blinded readers, who answered identical questions about enhancement of the lesion and liver in the arterial and portal venous phases and changes with time. Concordance for modalities was calculated from answers of readers and consensus answers between readers, with 95% confidence intervals (CIs). The kappa values were calculated for interreader agreement. RESULTS: Features of arterial phase enhancement showed concordance of more than 76% for modalities. The highest concordance of 92% (132 of 144), with 95% CI of 86% and 95% (kappa>0.84), was for the presence of peripheral pools and centripetal progression. Concordance in the portal venous phase was lower, with agreement for predominant enhancement of the lesion in 61% (86 of 142), with 95% CI of 52% and 68% (kappa>0.83). Portal venous phase washout occurred in 75% (106 of 142), with 95% CI of 67% and 81% (kappa>0.81). The majority of discordances were for malignancies for which only US depicted no sustained enhancement in the portal venous phase. CONCLUSION: US shows high concordance with CT or MR imaging, especially for the arterial phase. Discordance in the portal venous phase may reflect the tendency of CT and MR contrast agents, unlike microbubbles, to diffuse into interstitium.     

Contrast-enhanced peripheral MRA: technique and contrast agents

In the last decade contrast-enhanced magnetic resonance angiography (CE-MRA) has gained wide acceptance as a valuable tool in the diagnostic work-up of patients with peripheral arterial disease. This review presents current concepts in peripheral CE-MRA with emphasis on MRI technique and contrast agents. Peripheral CE-MRA is defined as an MR angiogram of the arteries from the aortic bifurcation to the feet. Advantages of CE-MRA include minimal invasiveness and lack of ionizing radiation. The basic technique employed for peripheral CE-MRA is the bolus-chase method. With this method a paramagnetic MRI contrast agent is injected intravenously and T1-weighted images are acquired in the subsequent arterial first-pass phase. In order to achieve high quality MR angiograms without interfering venous contamination or artifacts, a number of factors need to be taken into account. This includes magnetic field strength of the MRI system, receiver coil configuration, use of parallel imaging, contrast bolus timing technique, and k-space filling strategies. Furthermore, it is possible to optimize peripheral CE-MRA using venous compression techniques, hybrid scan protocols, time-resolved imaging, and steady-state MRA. Gadolinium(Gd)-based contrast agents are used for CE-MRA of the peripheral arteries. Extracellular Gd agents have a pharmacokinetic profile similar to iodinated contrast media. Accordingly, these agents are employed for first-pass MRA. Blood-pool Gd-based agents are characterized by prolonged intravascular stay, due to macromolecular structure or protein binding. These agents can be used for first-pass, as well as steady-state MRA. Some Gd-based contrast agents with low thermodynamic stability have been linked to development of nephrogenic systemic fibrosis in patients with severe renal insufficiency. Using optimized technique and a stable MRI contrast agent, peripheral CE-MRA is a safe procedure with diagnostic accuracy close to that of conventional catheter X-ray angiography.     

Normal anterior spinal arteries within the cervical region: high-spatial-resolution contrast-enhanced three-dimensional MR angiography

PURPOSE: To determine retrospectively whether the anterior spinal artery (ASA) is visualized in the cervical region with contrast material-enhanced high-spatial-resolution three-dimensional magnetic resonance (MR) angiography of the extracranial carotid and vertebral arteries. MATERIALS AND METHODS: The institutional research ethics committee approved this study and provided a waiver for informed consent. Data sets were evaluated in 50 consecutive patients referred for contrast-enhanced three-dimensional MR angiography of the carotid arteries (32 male and 18 female patients; age range, 15-80 years; mean age, 59 years). The ASA was defined as a linear area of high signal intensity that is seen anterior to the spinal cord in an arterial phase of enhancement and connects directly to a known arterial structure. If the linear area of high signal intensity was seen in the arterial phase but did not connect to a known arterial structure, it was considered a probable ASA. Venous enhancement was graded on a five-point scale (0-4) with grade 0 (no venous enhancement) or grade 1 (trace venous enhancement) considered to be in the arterial phase. RESULTS: The ASA was identified with certainty in 37 of 50 patients. A vessel visualized anterior to the spinal cord, which probably represented the ASA, was seen in another 11 of 50 patients. In 29 of 50 patients the vessel was visualized only on the full-volume maximum intensity projection (MIP) image. In the remainder of cases the artery was identified on operator-defined subvolume MIP images. Continuity between the vessel and the vertebrobasilar arterial structures was identified in 35 of 50 patients. The vessel was seen as a continuous structure throughout its length in 34 patients and appeared discontinuous in 14. Radiculomedullary feeders were identified in 24 of 50 patients. CONCLUSION: The normal cervical ASA was visualized in 48 of 50 of subjects with contrast-enhanced high-spatial-resolution three-dimensional MR angiography.     

Carotid artery: elliptic centric contrast-enhanced MR angiography compared with conventional angiography

PURPOSE: To determine the accuracy of elliptic centric contrast material-enhanced magnetic resonance (MR) angiography by using conventional angiography as the reference standard. MATERIALS AND METHODS: Fifty patients were examined prospectively with contrast-enhanced MR angiography and conventional angiography. The two examinations were performed within 1 week of each other. Two patients underwent conventional angiography of only one carotid artery, which yielded 98 arteries for comparison. RESULTS: With conventional angiography as the reference standard and by using a 70% threshold for internal carotid arterial diameter stenosis, maximum intensity projection (MIP) images had a sensitivity of 93.3%, specificity of 85.1%, and accuracy of 87.6%, whereas reformatted transverse source images had a sensitivity of 83.3%, specificity of 97.0%, and accuracy of 92.8%. Interobserver variability for conventional angiograms was 0.97, for MIP images was 0.91, and for source images was 0.90. The contrast-enhanced MR angiographic technique had a sensitivity of 88.9% and specificity of 58.1% for the presence of irregularity and/or ulceration. All 50 examinations were triggered appropriately so that minimal or no venous signal intensity was depicted. CONCLUSION: Contrast-enhanced elliptic centric three-dimensional MR angiography offers high-spatial-resolution, venous-suppressed images of the carotid arteries that appear to be adequate to replace conventional angiography in most patients examined prior to carotid endarterectomy.     

MR angiography of the thoracic vessels

Summary Through the introduction of newly invented high-performance gradient systems to MRI, which enable for echoplanar imaging (EPI), also magnetic resonance angiography (MRA) has gained an entirely new field of applications and techniques. Ultrafast imaging techniques in MRA allow the investigation of larger vascular areas within a single breathhold-period. Artifacts like motion induced signal misregistrations, dephasing or saturation of the vascular signal are minimized by extremely short echo times. The technique thus requires the intravenous application of a contrast media bolus, usually a gadolinium compound, which is in standard clinical use. Coordination of the bolus injection and the timing of the data acquisition is crucial for optimal results. The first pass evaluation of the contrast media resembles CTA to a certain extend. Due to the fast measurement and the high contrast in contrast-enhanced MRA (CE-MRA) new applications and indications are developed like MRA of the pulmonary vessels. The paper offers considerations and trials for optimization of thoracical CE-MRA. Besides parameter constellation also bolus-optimization is described with respect to the dedicated anatomical premises. Investigations on volunteers and on patients build a basis for suggestions on optimized CE-MRA procedures. To date, a final estimation of the clinical value of the new technique cannot be given since ongoing improvements change the optimal protocol frequently and the potential of further developments is high.      

Preliminary experience with contrast-enhanced MR angiography in patients with end-stage renal failure

RATIONALE AND OBJECTIVES: The purpose of this study was to evaluate our preliminary experience with routine contrast-enhanced magnetic resonance angiography (CE-MRA) of the lower limb arteries in patients with end-stage renal failure. MATERIALS AND METHODS: A retrospective analysis was performed on clinical, physiological, and imaging data for 104 patients with end-stage renal failure. Patients were considered to be in end-stage renal failure if they were on renal replacement therapy (peritoneal or hemodialysis) or were being evaluated as part of a pretransplant workup. CE-MRA was carried out on a 1.5-T scanner using a single-injection, three-station moving table technique. RESULTS: Eleven percent of asymptomatic patients with normal ankle/brachial pressure indexes (ABPI) were found to have severe arterial disease on CE-MRA, and in 30% of asymptomatic patients with abnormal ABPI, CE-MRA showed mild or no disease. Moreover two of three symptomatic patients with normal ABPI were shown to have severe disease. Two patients on peritoneal dialysis had to be switched to hemodialysis. No other adverse events were revealed. CONCLUSION: CE-MRA is a useful adjunct to clinical and physiological examination for the evaluation of the lower limb arteries in a group of patients who have a higher-than-average incidence of peripheral vascular disease, yet have previously been severely restricted from traditional angiography because of contrast-medium-induced nephrotoxicity.     

High-resolution imaging of the intracranial arterial and venous systems following a single contrast injection

PURPOSE: To generate two separate three-dimensional (3D) high spatial resolution images of the intracranial arterial and venous systems using a single contrast injection. MATERIALS AND METHODS: A 3D contrast-enhanced (CE) magnetic resonance angiography (MRA) acquisition was modified to create two separate k-space data sets to encode the arterial and venous enhancement signals individually after contrast agent injection. Following an automated detection of contrast arrival, the central k-space views corresponding to the arterial phase were acquired for the first eight seconds. A full elliptical-centric acquisition was then acquired for the venous phase and the missing views in the periphery of the first k-space data set were copied from the venous phase. A total of 18 patients underwent this study. Image quality, signal-to-noise ratio (SNR), and contrast-to-noise ratio (CNR) were determined in both intracranial systems. RESULTS: Two 3D image sets were generated for the arterial and venous intracranial systems. Both sets have high quality images that are clinically diagnostic. SNR and CNR were high in both sets, so that all the major vessels were visible. CONCLUSION: This technique provides images with high spatial resolution for both arterial and venous intracranial systems using a single contrast injection.     

High-resolution time-resolved contrast-enhanced MR abdominal and pulmonary angiography using a spiral-TRICKS sequence.

Both high spatial resolution and high temporal resolution are desirable for contrast-enhanced magnetic resonance angiography (CE-MRA) in order to depict the arterial vasculature. In this work a fast MR pulse sequence (spiral time-resolved imaging with contrast kinetics (Spiral-TRICKS)) with spiral readout in-plane and Cartesian slice encoding was developed whereby the slices are partitioned into multiple regions and acquired in the order used with the TRICKS sequence. The combination of highly efficient spiral sampling with TRICKS acquisition significantly reduced imaging time requirements. A unit second temporal reconstructed frame rate could be achieved for three-dimensional (3D) CE-MRA without undersampling of the spiral trajectories. Image quality was improved through spiral trajectory measurement and field-map correction. Phantom and volunteer studies were performed to demonstrate the feasibility of this technique.     

Contrast-enhanced peripheral MR angiography using SENSE in multiple stations: feasibility study

PURPOSE: To investigate if the use of parallel imaging is feasible and beneficial for peripheral contrast-enhanced magnetic resonance angiography (CE-MRA). MATERIALS AND METHODS: A total of 19 consecutive patients underwent peripheral CE-MRA using SENSE with two-fold reduction in the upper and lower leg stations. Conventional nonaccelerated imaging using constant level appearance (CLEAR) was used in the aortoiliac station. The findings were compared with those in a similar patient group that underwent peripheral CE-MR angiography using our standard imaging protocol without SENSE. Intraarterial digital subtraction angiography (IA-DSA) was used as the standard of reference. Lower extremity vessels were divided into anatomic segments (aortoiliac, upper legs, lower legs) for review. In each anatomic segment signal- and contrast-to-noise ratios (SNR, CNR), venous contamination, subjective image quality, as well as sensitivity and specificity, were determined for both patient groups. RESULTS: SNR and CNR improved significantly for the aortoiliac and upper leg segments (all P-values < or = 0.001). Small reductions were seen in the frequency of disturbing venous enhancement (P = not significant). There were no significant differences with regards to subjective image quality or diagnostic accuracy (all P > 0.3). Overall sensitivity and specificity in the SENSE group were 81% and 95%, respectively. For the non-SENSE group, these values were 79% and 96%, respectively. CONCLUSION: Preliminary results show that three-station peripheral CE-MRA using a full length peripheral arterial coil in combination with SENSE in the upper and lower leg stations is feasible and useful for further optimization of peripheral MRA. Using SENSE allows for routine, high-quality depiction of the entire peripheral vascular tree including the pedal arch. Higher SENSE factors are needed for further optimization.     

MR portal venography: preliminary results of fast acquisition without contrast material or breath holding

RATIONALE AND OBJECTIVES: The authors performed this study to evaluate the feasibility of using the steady-state free precession (SSFP) sequence to perform magnetic resonance (MR) venography of the portal venous system without the use of contrast material or breath holding. MATERIALS AND METHODS: Eleven patients underwent MR venography with the SSFP technique. Coronal three-dimensional images were obtained with respiratory triggering. Contrast material and respiratory suspension were not used. All patients had recently undergone at least one other imaging study (conventional angiography, transhepatic portal venography, ultrasound, or contrast-enhanced computed tomography), and these findings were correlated with those from MR venography. The structures evaluated were the main portal vein, right portal vein, left portal vein, superior mesenteric vein, and splenic vein. RESULTS: MR venography with SSFP accurately depicted the status of these veins in all cases except one. In this patient, MR venography depicted portal vein thrombus but could not indicate that it was tumor thrombus. CONCLUSION: MR venography with SSFP accurately depicted the portal venous system in 10 of 11 patients without the use of respiratory suspension or contrast material.     

Adamkiewicz动脉的MR血管成像

目的 前瞻性研究对比剂增强MR血管成像(CE-MRA)显示Adamkiewicz动脉的可行性,在外科术前对脊髓血管进行评估,为脊柱外科的诊断与治疗提供参考.方法 10名志愿者及15例胸腰段椎间盘突出的患者术前行CE-MRA扫描,范围包括胸腹主动脉及其分支.扫描序列采用三维扰相梯度回波序列(3D-SPGR),注射对比剂量为0.3 mmol/kg.结果 在所有受检者中,脊髓前正中动脉(ASA)、Adamkiewicz及节段动脉均显示良好,所有患者的Adamkiewicz动脉均起源于T8～ L2之间.其中起源于左侧20例,右侧5例.ASA显示的范围T6～L3.Adamkiewicz动脉的直径为0.6～1.2 mm,ASA直径为0.6～1.0 mm.结论 CE-MRA扫描能对Adamkiewicz动脉进行准确的定位并能够提供可靠的信息,对临床有一定的应用价值.     

First-pass contrast-enhanced magnetic resonance angiography in humans using ferumoxytol, a novel ultrasmall superparamagnetic iron oxide (USPIO)-based blood pool agent

PURPOSE: To evaluate the feasibility of first-pass contrast-enhanced magnetic resonance angiography (MRA) using ferumoxytol in humans. MATERIALS AND METHODS: First-pass and equilibrium phase MRA were performed using ferumoxytol in one healthy volunteer and 11 patients with a fast three-dimensional spoiled gradient recalled (SPGR) pulse sequence. The examined vessels included carotid arteries, thoracic aorta, abdominal aorta, and peripheral arteries. A dose of either 71.6 micromol Fe/kg (n = 9), or 35.8 micromol Fe/kg (n = 3) was used. Based on a phantom study, the agent with initial concentration of 537.2 micromol Fe/mL was diluted by either four-fold (134.3 micromol Fe/mL) or eight-fold (67.1 micromol Fe/mL) for first-pass MRA. RESULTS: All subjects completed their studies without adverse events. First-pass MRA showed selective arterial enhancement, with both arterial and venous enhancement on delayed acquisitions. Selective venous enhancement could be obtained by subtraction of arterial phase images from equilibrium phase images. The findings in ferumoxytol MRA were consistent with the results of original vascular tests. CONCLUSION: Our preliminary experience supports the feasibility of first-pass MRA with ferumoxytol. Satisfactory arterial enhancement during first-pass imaging is obtained with injection of diluted contrast agent. With ferumoxytol, arteries and veins can be selectively depicted in a single exam.     

Time-resolved contrast-enhanced magnetic resonance angiography in pediatric patients using sensitivity encoding

PURPOSE: To evaluate the role of time-resolved contrast-enhanced magnetic resonance angiography (CE-MRA) using sensitivity encoding in imaging the thoraco-abdominal vessels in pediatric patients. MATERIALS AND METHODS: Thoraco-abdominal vessels of 22 pediatric patients (median age = 5 years) were evaluated with a 3D CE-MRA technique in combination with SENSE following a 0.2 mmol/kg injection of Gd-chelate. The acquisition parameters were as follows: TR/TE = 5/1.1 msec; flip angle = 40 degrees; in-plane phase encoding steps were reduced by a factor of 2 using sensitivity encoding (SENSE); 3D volume acquisition was repeated four to eight times consecutively during free breathing (four to eight dynamics) with a mean temporal resolution of 6.8 seconds/dynamic; and mean acquired voxel size = 1.4 x 1.7 x 3.1 mm (reconstructed as 1.4 x 1.4 x 1.55 mm). Arterial-to-venous signal intensity ratios (AVRs) were computed for each dynamic. RESULTS: All images were successfully reconstructed and were of diagnostic quality. The AVRs of prepeak, peak, and postpeak arterial volumes were 1.0 +/- 0.5, 6.1 +/- 3.3, and 1.3 +/-0.9, respectively, indicating good arterial-to-venous separation. The signal-to-noise ratio (SNR) of the peak arterial volume was 41 +/- 26. CONCLUSION: Our results suggest that it is feasible to apply SENSE to a conventional 3D CE-MRA technique in a time-resolved fashion for imaging the thoraco-abdominal vessels in pediatric patients during free breathing.     

Contrast-enhanced three-dimensional MR portography.

Three-dimensional (3D) magnetic resonance (MR) portography with contrast material enhancement is a fast means of evaluating the portal venous system that has some advantages over currently used modalities, such as digital subtraction angiography, helical computed tomography, ultrasonography, and nonenhanced MR angiography with time-of-flight and phase-contrast techniques. With contrast-enhanced 3D MR portography, a first-pass study of the mesenteric vasculature is performed after rapid bolus injection of gadopentetate dimeglumine; a 3D fast field echo sequence is used, which can demonstrate the intrahepatic and extrahepatic portal venous system clearly. Repeated sequences after administration of gadopentetate dimeglumine allow separate demonstration of the splanchnic arteries and portomesenteric veins. The images are reconstructed by means of maximum-intensity projection postprocessing, and a subtraction technique can be used to eliminate arterial enhancement and demonstrate portosystemic shunts. The coronal source images simultaneously demonstrate parenchymal lesions of the liver, pancreas, biliary tract, and spleen. This technique is clinically indicated in portosystemic shunt, portal vein thrombosis, hepatocellular carcinoma, pancreatobiliary tumor, hepatic vein obstruction, differentiation of splanchnic arterial from portal venous disease, and gastrointestinal hemorrhage. Its limitations include allergic reactions to contrast media, inappropriate positioning of the 3D acquisition slab, respiratory motion artifacts, and pseudodissection.     

Time-resolved, high-resolution contrast-enhanced MR angiography of dialysis shunts using the CENTRA keyhole technique with parallel imaging

PURPOSE: To evaluate the use of a dynamic keyhole magnetic resonance angiography (MRA) sequence combined with sensitivity encoding (SENSE) for hemodialysis shunts, because surveillance with conventional contrast-enhanced MRA (CE-MRA) is limited by its low temporal resolution, resulting in arteriovenous overlay. MATERIALS AND METHODS: A total of 12 patients with Brescia-Cimino shunts were investigated prospectively using the new technique. During the contrast passage (gadoterate, Gd-DOTA) a series of five to nine dynamic central k-space measurements (10% for upper-arm shunt, 25% for lower-arm shunt) followed by a full reference data set were acquired. The outer k-space data of the single reference scan were used to complete the dynamic data sets. RESULTS: All studies were diagnostic (17 stenoses, three aneurysms) without complications. The acquisition times for a single dynamic scan of the upper- and lower-arm shunts were 2.2 and 3.2 seconds, respectively, while the reference scan needed 13 and 22.4 seconds, respectively. The dynamic angiograms allowed the differentiation of arterial and venous filling despite a mean peak delay time of only 4.2 seconds in the shoulder region. Image quality qualified in consensus by two experienced readers was rated "good" in 19 cases and "intermediate" in five cases with high mean values for signal-to-noise ratios (SNRs) and contrast-to-noise-ratios (CNRs). CONCLUSION: We have successfully implemented a fast, dynamic, CE-MRA technique with CE timing robust angiography (CENTRA) keyhole and SENSE in clinical routine. High spatial and temporal resolution improve the diagnostics of dialysis shunts and allow the assessment of detailed, dynamic, four-dimensional (4D) information.     

Breath-hold contrast-enhanced three-dimensional MR angiography of the abdomen: time-resolved imaging versus single-phase imaging

PURPOSE: To evaluate a technique for time-resolved breath-hold contrast material-enhanced three-dimensional magnetic resonance (MR) angiography of the abdomen. MATERIALS AND METHODS: In a prospective study, 43 patients underwent time-resolved MR angiography (acquisition time per data set, 7 seconds). The patients also underwent single-phase high-spatial-resolution MR angiography (acquisition time, 27 seconds) (n = 6), conventional angiography (n = 7), or both (n = 30). No bolus timing study was performed for time-resolved MR angiography. Image quality (presence of artifacts, ability to prevent venous overlap on arterial phase images, contrast enhancement) and demonstration of anatomic variants (renal arterial and venous variants, vena caval anomaly, visceral arterial variants) and vascular diseases were assessed. RESULTS: Time-resolved MR angiographic images were characterized by fewer and less severe artifacts, less overlap of enhancing veins, and better contrast enhancement than were single-phase MR angiographic images (P < .05). The mean sensitivity and specificity were 90% (nine of 10) and 100% (1 73 of 1 73), respectively, for detection of arterial anatomic variants and 93% (28 of 30) and 100% (324 of 325), respectively, for detection of disease. The technique also proved to be reliable for demonstration of venous disease. CONCLUSION: In comparison with current non-time-resolved MR angiographic techniques, time-resolved MR angiography is more robust and easier to perform and allows simultaneous evaluation of arterial and venous disease.     

Evaluating contrast kinetics by acquiring 2D images during 3D contrast-enhanced MR angiography

PURPOSE: To monitor contrast kinetics by acquiring multiple 2D images during 3D contrast-enhanced magnetic resonance angiography (CE MRA). MATERIALS AND METHODS: A 2D real-time autotriggering tool was integrated into a 3D sequence, enabling it to run multiple times during 3D acquisition. Several dummy scans were applied after each transition to maintain the steady state condition of both sequences. The number of the acquired 2D images and their distribution can be adjusted. Each 2D image was saved along with its associated timing. Contrast signal variations over time were plotted, reflecting selective signal measurement over an artery and vein from the saved 2D images. RESULTS: Different contrast kinetics timings were calculated from the resulting plot. Contrast arrival time to the internal cerebral artery was 13.2 +/- 1.2 seconds and the peak arterial to peak venous (at the confluence of sinuses) enhancement was 6.7 +/- 0.6 seconds. The observed timing could be used for 3D sequence optimization; the saved 2D images are useful in detecting and characterizing vascular abnormalities. CONCLUSION: Integrating 2D and 3D sequences into one sequence to monitor contrast kinetics through the neurovasculature is feasible without the need for extra injections or reduced spatial resolution. The technique can also be used in different parts of the body to extract useful clinical information.